bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy.
LOVTRAP: an optogenetic system for photoinduced protein dissociation.
Nature Methods
Wang, Hui H; Vilela, Marco M; Winkler, Andreas A; Tarnawski, Miroslaw M; Schlichting, Ilme I; Yumerefendi, Hayretin H; Kuhlman, Brian B; Liu, Rihe R; Danuser, Gaudenz G; Hahn, Klaus M KM